近日,来自英国格拉斯哥大学的研究者们在J Exp Clin Cancer Res.杂志上发表了题为“JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors”的文章,该研究表明抑制JAK/STAT3是一种有希望的治疗富含基质的结直肠癌患者的策略。
Kathryn A. F . Pennel et al. JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors. J Exp Clin Cancer Res. 2024 Mar 1;43(1):64. doi: 10.1186/s13046-024-02958-4.